OTCM
INND
Market cap861kUSD
Jul 09, Last price
0.00USD
1D
0.00%
1Q
-75.00%
IPO
-100.00%
Name
InnerScope Hearing Technologies, Inc.
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
InnerScope Hearing Technologies, Inc. specializes in delivering a variety of hearing solutions, primarily supplying the retail hearing aid community with its array of hearing aids and personal sound amplification devices, available in both hearable and wearable forms. The company's operations encompass the manufacturing and direct-to-consumer distribution and sales of these devices. Beyond hardware, InnerScope also offers a suite of related products and services, which include hearing-related therapeutic treatments, physician-developed dietary supplements aimed at supporting hearing health, and a unique CBD oil specifically formulated for managing tinnitus. Expanding its comprehensive approach, InnerScope manages and operates eleven audiological and retail hearing device clinics. Additionally, it provides a business-to-business (B2B) software-as-a-service (SaaS) platform for patient management. Founded in 2012 as Innerscope Advertising Agency, Inc., the company officially adopted its current name, InnerScope Hearing Technologies, Inc., in August 2017, and its corporate headquarters are located in Roseville, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||